vimarsana.com

Latest Breaking News On - Thomas louie - Page 1 : vimarsana.com

Fecal transplant pill knocks out recurrent C diff infection, study shows

High-Dose VE303 Prevents Recurrent Clostridioides Difficile Infection

WEDNESDAY, April 19, 2023 (HealthDay News) For adults with laboratory-confirmed Clostridioides difficile infection (CDI) at high risk for recurrence, high-dose VE303, a defined bacterial consortium of eight strains of commensal Clostridia, prevents recurrent CDI, according to a study published online April 15 in the Journal of the American Medical Association to coincide with the

High-Dose VE303 Prevents Recurrent Clostridioides Difficile Infection

High-Dose VE303 Shows Promise Treating Patients at Risk of Recurrent CDI

The rate of CDI recurrence through week 9 using the efficacy analysis 3 definition was 13.8% for the high-dose VE303 group, compared to 37% for the low-dose VE303 group and 45.5% for the placebo group.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.